GI-View is introducing a new generation of endoscopy products for gastrointestinal applications based on unique visualization and self-propelled pneumatic intubation technology. The company’s flagship Aer-O-Scope Colonoscope is a disposable, self-propelled colonoscope incorporating a miniature 360° omni-directional camera. The company’s intent, is to help GI clinics and hospital outpatient departments (HOPDs) efficiently screen patients in a way that is aligned with existing clinic workflows.
Pre-clinical and clinical trials were performed to substantiate 360° visualization capabilities as well as safety and intubation rate targets. The Aer-O-Scope colonoscope principal trial in Israel was conducted as part of an FDA 510(k) premarket submission.
The company mission is to fundamentally change the way colorectal cancer screening is performed and meet demand with a new paradigm in the continually growing screening arena. GI-View has been granted ISO certification for quality systems.
GI-View has a diverse and strong IP portfolio which includes several dozen patent applications worldwide. To date, 55 patents have been granted.
Israel Healthcare Ventures Ltd
Ziegler Meditech Equity Partners
GI View Ltd. Receives FDA 510(k) Clearance for the New Aer-O-Scope® Disposable Colonoscope System with Working Channels for Therapeutic Intervention During Colorectal Cancer Screening
Check out our clinical trial results published in GIE
Our in-vivo visualization study results have been published in Endoscopy International Open
"The 360° omni-view visualization helps to see pathologies behind haustral folds. I am confident the Aer-O-Scope will enhance our ADR.”Erwin Santo MD, Head, Department of Gastroenterology and Liver Diseases Tel Aviv Sourasky Medical Center